Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share

Statistics for the 2023 & 2024 Autologous Stem Cell and Non-Stem Cell Based Therapies market share, created by Mordor Intelligence™ Industry Reports. Autologous Stem Cell and Non-Stem Cell Based Therapies share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Autologous Stem Cell and Non-Stem Cell Based Therapies Industry

The global autologous stem cell and non-stem cell-based therapies market is competitive, fragmented, and consists of a few major players. The companies, which include Novartis AG, BrainStorm Cell Limited, Caladrius, Cytori Therapeutics Inc., Dendreon Pharmaceuticals LLC, Gilead Sciences Inc., Regeneus Ltd, and US Stem Cell Inc., among others, hold a substantial share in the growth of the market studied.

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Leaders

  1. BrainStorm Cell Limited.

  2. Cytori Therapeutics Inc.

  3. Dendreon Pharmaceuticals LLC

  4. Novartis AG

  5. U.S. Stem Cell, Inc.

*Disclaimer: Major Players sorted in no particular order

Autologous Stem Cell and Non-Stem Cell Based Therapies Market.png

Autologous Stem Cell & Non-Stem Cell Based Therapies Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)